Cargando…

Commentary: Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults—nine states, January–September 2021

Detalles Bibliográficos
Autor principal:	Anesi, Judith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2022
Materias:	Cdc Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805400/ https://www.ncbi.nlm.nih.gov/pubmed/34967123 http://dx.doi.org/10.1111/ajt.16910

Ejemplares similares

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021
por: Embi, Peter J., et al.
Publicado: (2022)

Commentary: The Advisory Committee on Immunization Practices’ ethical principles for allocating initial supplies of COVID-19 vaccine — United States, 2020
por: Fishman, Jay
Publicado: (2021)

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021
por: Embi, Peter J., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020
por: McClung, Nancy, et al.
Publicado: (2021)

Knowledge and practices regarding safe household cleaning and disinfection for COVID-19 prevention — United States, May 2020
por: Gharpure, Radhika, et al.
Publicado: (2020)

Paxlovid associated with decreased hospitalization rate among adults with COVID-19 — United States, April–September 2022
por: Shah, Melisa M., et al.
Publicado: (2023)

Potential indirect effects of the COVID-19 pandemic on use of emergency departments for acute life-threatening conditions — United States, January–May 2020
por: Lange, Samantha J., et al.
Publicado: (2020)

Impact of hospital strain on excess deaths during the COVID-19 pandemic—United States, july 2020–july 2021
por: French, Geoffrey, et al.
Publicado: (2022)

Commentary
por: Parisot, Nelly, et al.
Publicado: (2015)

Commentary
por: Chen, Kuan-Fu, et al.
Publicado: (2009)

Commentary
por: Rothman, Richard E., et al.
Publicado: (2007)

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021
por: Bozio, Catherine H., et al.
Publicado: (2021)

Detection and genetic characterization of community-based SARS-CoV-2 infections – New York City, March 2020
por: Bushman, Dena, et al.
Publicado: (2020)

Detection and genetic characterization of community-based SARS-CoV-2 infections — New York City, March 2020
por: Fishman, Jay A.
Publicado: (2020)

Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January−September 2021
por: Sacco, Chiara, et al.
Publicado: (2021)

Commentary of the mRNA vaccines COVID-19
por: Vitiello, Antonio, et al.
Publicado: (2021)

Risk of hospitalization and death for healthcare workers with COVID-19 in nine European countries, January 2020–January 2021
por: Ferland, L., et al.
Publicado: (2022)

Effect of COVID-19 vaccination on mortality by COVID-19 and on mortality by other causes, the Netherlands, January 2021–January 2022
por: de Gier, Brechje, et al.
Publicado: (2023)

Influenza incidence and vaccine effectiveness during the Southern Hemisphere Influenza season—Chile, 2022
por: Barraza, María Fernanda Olivares, et al.
Publicado: (2022)

COVID-19 contact tracing in Belgium: main indicators and performance, January – September 2021
por: Proesmans, Kristiaan, et al.
Publicado: (2022)

Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
por: Hause, Anne M., et al.
Publicado: (2021)

COVID-19 Vaccination Perspectives and Illnesses Among Law Enforcement Officers, Firefighters, and Other First Responders in the US, January to September 2021
por: Caban-Martinez, Alberto J., et al.
Publicado: (2022)

COVID-19 vaccination in immunocompromised patients
por: Sonani, Bhavin, et al.
Publicado: (2021)

COVID-19 Booster Vaccination in the U.S. Military, August 2021–January 2022
por: Winkler, Erin L., et al.
Publicado: (2023)

Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients
por: Solera, Javier T, et al.
Publicado: (2023)

Cardiac Complications After SARS-CoV-2 Infection and mRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022
por: Block, Jason P., et al.
Publicado: (2022)

Administration of COVID-19 vaccines in immunocompromised patients
por: Negahdaripour, Manica, et al.
Publicado: (2021)

Vaccines and therapeutics for immunocompromised patients with COVID-19
por: Shoham, Shmuel, et al.
Publicado: (2023)

Community-Associated Outbreak of COVID-19 in a Correctional Facility — Utah, September 2020–January 2021
por: Lewis, Nathaniel M., et al.
Publicado: (2021)

Estimating excess mortalities due to the COVID-19 pandemic in Malaysia between January 2020 and September 2021
por: Jayaraj, Vivek Jason, et al.
Publicado: (2023)

COVID-19 Vaccination Status, Attitudes, and Values among US Adults in September 2021
por: Dudley, Matthew Z., et al.
Publicado: (2022)

COVID-19 Vaccine Effectiveness: A Review of the First 6 Months of COVID-19 Vaccine Availability (1 January–30 June 2021)
por: Hatcher, Sarah M., et al.
Publicado: (2022)

mRNA COVID-19 vaccine booster fosters B- and T-cell responses in immunocompromised patients
por: Azzolini, Elena, et al.
Publicado: (2022)

Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
por: Obeid, Michel, et al.
Publicado: (2022)

Immune Response to COVID-19 and mRNA Vaccination in Immunocompromised Individuals: A Narrative Review
por: Napuri, Norka I., et al.
Publicado: (2022)

Re: Unilateral axillary adenopathy in the setting of COVID-19 vaccine, Clinical Imaging, January 2021
por: Finnegan, John, et al.
Publicado: (2021)

Association of Uninsurance and VA Coverage with the Uptake and Equity of COVID-19 Vaccination: January–March 2021
por: Gaffney, Adam W, et al.
Publicado: (2022)

Immunocompromised patients in the USA and UK should receive third dose of COVID-19 vaccine
por: Furlow, Bryant
Publicado: (2021)

COVID-19 vaccines for high risk and immunocompromised patients
por: Pavia, Charles S., et al.
Publicado: (2022)

Safety and immunogenicity of COVID-19 vaccination in immunocompromised patients
por: Song, Jin-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1v21g0kvcecrgvccp2keqvmgaa